Literature DB >> 26455999

Magnetic resonance imaging of Hoffa's fat pad and relevance for osteoarthritis research: a narrative review.

F W Roemer1, M Jarraya2, D T Felson3, D Hayashi4, M D Crema5, D Loeuille6, A Guermazi7.   

Abstract

OBJECTIVE: To give an illustrative overview of Hoffa's fat pad pathology with a radiologic emphasis on the anatomy, on technical considerations, and on imaging differential diagnoses in the context of osteoarthritis (OA) imaging research.
DESIGN: A PubMed database search including only English literature and covering a 20 year period was performed. The search was based on but no limited to the query terms "Hoffa", "Hoffa's fat pad" or "infrapatellar fat pad (IPFP)" in combination with "synovitis", "OA", and "magnetic resonance imaging (MRI)". The literature search yielded 289 publications that were screened for relevance; additional references were included when these were considered of importance.
RESULTS: Several anatomic variants and pathologic conditions may be encountered when assessing Hoffa's fat pad including tumors and tumor-like lesions such as osteochondroma, tenosynovial giant cell tumor (TGCT) (and pigmented nodular synovitis) and arthrofibrosis, traumatic changes including contusions and anatomic variants such as recesses. The latter may be accountable for differences in cross-sectional area or volume changes over time. Signal changes are commonly used in OA research as surrogate markers for synovitis but are non-specific findings.
CONCLUSIONS: Quantitative approaches to evaluate 3D parameters of Hoffa's fat pad are increasingly applied and their role in regard to structural progression and clinical manifestations of disease needs to be further elucidated. In applying such approaches, knowledge of the detailed anatomy and potential pitfalls that may be a result of anatomical variants, inflammatory disease manifestations and additional diverse pathologies encountered seems to be paramount.
Copyright © 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hoffa's fat pad; Inflammation; Infrapatellar fat pad; MRI; Osteoarthritis

Mesh:

Year:  2015        PMID: 26455999     DOI: 10.1016/j.joca.2015.09.018

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  20 in total

1.  Profibrotic Infrapatellar Fat Pad Remodeling Without M1 Macrophage Polarization Precedes Knee Osteoarthritis in Mice With Diet-Induced Obesity.

Authors:  Erika Barboza; Joanna Hudson; Wan-Pin Chang; Susan Kovats; Rheal A Towner; Robert Silasi-Mansat; Florea Lupu; Collin Kent; Timothy M Griffin
Journal:  Arthritis Rheumatol       Date:  2017-04-28       Impact factor: 10.995

2.  Advanced Hemophilic Arthropathy: Sensitivity of Soft Tissue Discrimination With Musculoskeletal Ultrasound.

Authors:  Annette von Drygalski; Randy E Moore; Sonha Nguyen; Richard F W Barnes; Lena M Volland; Tudor H Hughes; Jiang Du; Eric Y Chang
Journal:  J Ultrasound Med       Date:  2018-01-24       Impact factor: 2.153

3.  Between-group differences in infra-patellar fat pad size and signal in symptomatic and radiographic progression of knee osteoarthritis vs non-progressive controls and healthy knees - data from the FNIH Biomarkers Consortium Study and the Osteoarthritis Initiative.

Authors:  A Ruhdorfer; F Haniel; T Petersohn; J Dörrenberg; W Wirth; T Dannhauer; D J Hunter; F Eckstein
Journal:  Osteoarthritis Cartilage       Date:  2017-02-12       Impact factor: 6.576

4.  Hyperintense signal alteration in the suprapatellar fat pad on MRI is associated with degeneration of the patellofemoral joint over 48 months: data from the Osteoarthritis Initiative.

Authors:  Benedikt J Schwaiger; John Mbapte Wamba; Alexandra S Gersing; Michael C Nevitt; Luca Facchetti; Charles E McCulloch; Thomas M Link
Journal:  Skeletal Radiol       Date:  2017-09-24       Impact factor: 2.199

Review 5.  Imaging of osteoarthritis-recent research developments and future perspective.

Authors:  Daichi Hayashi; Frank W Roemer; Ali Guermazi
Journal:  Br J Radiol       Date:  2018-01-19       Impact factor: 3.039

6.  Impact of Diet and/or Exercise Intervention on Infrapatellar Fat Pad Morphology: Secondary Analysis from the Intensive Diet and Exercise for Arthritis (IDEA) Trial.

Authors:  Aarón Leonardo Pogacnik Murillo; Felix Eckstein; Wolfgang Wirth; Daniel Beavers; Richard F Loeser; Barbara J Nicklas; Shannon L Mihalko; Gary D Miller; David J Hunter; Stephen P Messier
Journal:  Cells Tissues Organs       Date:  2017-02-22       Impact factor: 2.481

7.  Is superolateral Hoffa's fat pad hyperintensity a marker of local patellofemoral joint disease? - The MOST study.

Authors:  M Jarraya; A Guermazi; D T Felson; F W Roemer; M C Nevitt; J Torner; C E Lewis; J J Stefanik
Journal:  Osteoarthritis Cartilage       Date:  2017-06-09       Impact factor: 6.576

8.  Relationship of Trochlear Morphology and Patellofemoral Joint Alignment to Superolateral Hoffa Fat Pad Edema on MR Images in Individuals with or at Risk for Osteoarthritis of the Knee: The MOST Study.

Authors:  Rafael Widjajahakim; Michael Roux; Mohamed Jarraya; Frank W Roemer; Tuhina Neogi; John A Lynch; Cora E Lewis; James C Torner; David T Felson; Ali Guermazi; Joshua J Stefanik
Journal:  Radiology       Date:  2017-04-17       Impact factor: 11.105

9.  Associations between serum IL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis.

Authors:  Guangfeng Ruan; Jianhua Xu; Kang Wang; Shuang Zheng; Juan Wu; Fuqin Bian; Bingru Chang; Yan Zhang; Tao Meng; Zhaohua Zhu; Weiyu Han; Changhai Ding
Journal:  Clin Rheumatol       Date:  2019-08-03       Impact factor: 2.980

10.  Quantitative volume and dynamic contrast-enhanced MRI derived perfusion of the infrapatellar fat pad in patellofemoral pain.

Authors:  Rianne A van der Heijden; Bas A de Vries; Dirk H J Poot; Marienke van Middelkoop; Sita M A Bierma-Zeinstra; Gabriel P Krestin; Edwin H G Oei
Journal:  Quant Imaging Med Surg       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.